Skip to main content
Log in

Procoagulant activity of gastric, colorectal, and renal cancer is factor VII-dependent

  • Original Papers
  • Clinical Oncology or Epidemiology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Summary

The PA of GC, CC, and RC extracts was assayed by the recalcification of human normal or F VII-DP, and the PA of normal tissue was also determined. The PA of normal tissue was higher than that of the cancer tissues in all groups of specimens. Substitution of normal plasma by F VII-DP resulted in significant depression of the PA and the differences in the PA between the normal and cancer tissue samples disappeared. Preincubation of normal and cancer tissue extracts with the cysteine proteinase inhibitors, mercuric chloride and iodoacetamide, did not affect the PA of these extracts. We conclude that the PA of the investigated cancer extracts is factor VII-dependent and can be related to the presence of tissue factor within cancer tissue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

PA:

procoagulant activity

GC:

gastric cancer

CC:

colorectal cancer

RC:

renal cancer

PPP:

platelet-poor plasma

F VII-DI:

factor VII-deficient plasma

DFP:

diisopropylfluorophosphate

References

  • Al-Mondhiry H, McGarvey V, Leitzel K (1983) Interaction of human tumor cells with human platelets and the coagulation system. Thromb Hacmost 50:726–730

    Google Scholar 

  • Cajot J-F, Kruithof EKO, Schleuming W-D, Sordat B, Bachmann F (1986) Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines. Int J Cancer 38:719–727

    Google Scholar 

  • Colucci M, Curatolo L, Donati MB, Semeraro N (1980) Cancer cell procoagulant activity: Evaluation by amidolytic assay. Thromb Res 18:589–595

    Google Scholar 

  • Curatolo L, Alessio G, Passerini CG, Casali B, Morasca L, Semeraro N, Donati MB (1985) Procoagulant activity of mouse and human cultured cells following various types of transformation. Int J Cancer 35:411–414

    Google Scholar 

  • Dvorak MF, Senger DR, Dvorak AM (1983) Fibrin as a component of the tumor stroma: origins and biological significance. Cancer Metastasis Rev 2:41–73

    Google Scholar 

  • Falanga A, Gordon SG (1985) Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue. Biochemistry 24:5558–5567

    Google Scholar 

  • Gordon SG (1986) Cancer cell procoagulants and their possible role in metastasis. In: KV Honn, WE Powers, BF Sloane (eds) Mechanisms of cancer metastasis. Martinus Nijhoff, Boston, pp 159–172

    Google Scholar 

  • Gordon SG, Cross BA (1981) A factor X-activating cysteine protease from malignant tissue. J. Clin Invest 67:1665–1671

    Google Scholar 

  • Gordon SG, Franks JJ, Lewis B (1975) Cancer procoagulant A: a factor X activating procoagulant from malignant tissue. Thromb Res 6:127–137

    Google Scholar 

  • Gordon SG, Franks JJ, Lewis BJ (1979) Comparison of procoagulant activities in extracts of normal and malignant human tissue. J Natl Cancer Inst 62:773–776

    Google Scholar 

  • Kadish JL, Wenc KM, Dvorak HF (1983) Tissue factor activity of normal and neoplastic cells: quantitation and species specificity. J Natl Cancer Inst 70:551–557

    Google Scholar 

  • Kinjo M, Oka K, Naito S, Kohga S, Tanaka K, Oboshi S, Hayata Y, Yasumoto K (1979) Thromboplastic and fibrinolytic activities of cultured human cancer cell lines. Br J Cancer 39:15–23

    Google Scholar 

  • Lowry OH, Rosenbrough NJ, Farr AL, Randal RJ (1951) Protein measurements with Folin phenol reagent. J Biol Chem 193:265–275

    Google Scholar 

  • Sakuragawa N, Takanashi K, Hoshiyama M, Jimbo C, Ashizawa K, Matsuoka M, Ohnisi Y (1977) The extract from the tissue of gastric cancer as procoagulant in disseminated intravascular coagulation syndrome. Thromb Res 10:457–463

    Google Scholar 

  • Sun NC, McAfee WM, Hum GJ, Weiner JM (1979) Hemostatic abnormalities in malignancy, a prospective study of one hundred eight patients. Part I. Coagulation studies. Am J Clin Pathol 71:10–16

    Google Scholar 

  • Szczepański M, Lucer C, Zawadzki J, Tołłoczko T (1982) Procoagulant and fibrinolytic activities of gastric and colorectal cancer. Int J Cancer 30:329–333

    Google Scholar 

  • Zacharski LR (1984) Rationale for anticoagulant treatment of cancer. In: KV Honn (ed) Hemostatic mechanisms and metastasis. Martinus Nijhoff, Boston, pp 368–374

    Google Scholar 

  • Zacharski LR, Rosenstein R, Phillips PG (1981) Tissue factor: a vitamin K-dependent clotting factor? Ann NY Acad Sci 370:311–324

    Google Scholar 

  • Zacharski LR, Schned AR, Sorenson GD (1983) Occurrence of fibrin and tissue factor antigen in human small cell carcinoma of the lung. Cancer Res 43:3963–3968

    Google Scholar 

  • Zacharski LR, Memoli VA, Rousseau SM (1986) Coagulation-cancer interaction in situ in renal cell carcinoma. Blood 68:394–399

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Szczepański, M., Bardadin, K., Zawadzki, J. et al. Procoagulant activity of gastric, colorectal, and renal cancer is factor VII-dependent. J Cancer Res Clin Oncol 114, 519–522 (1988). https://doi.org/10.1007/BF00391504

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00391504

Key words

Navigation